<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Blood Formation & Coagulation | Pharmacology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true
        },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Links populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-07-antineoplastics.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">8</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">16</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 50%;"></div>
                            </div>
                            <span class="progress-label">Blood Drugs</span>
                        </div>
                        
                        <a href="topic-09-cardiovascular.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Blood Formation & Coagulation</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">ü©∏</span>
                        <span class="badge-text">Unit 8</span>
                    </div>
                    <h1 class="document-title">Drugs Affecting Blood Formation and Coagulation</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Pages 56-64</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>25 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content -->
                <div class="content-wrapper">
                    <!-- START: antianemic-drugs -->
                    <section id="antianemic-drugs" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">Antianemic Drugs</h2>
                        </div>
                        
                        <div class="content-card">
                            <p><strong>‚û¢Anemia:</strong> Refers to many clinical conditions in which there is a deficiency in the number of RBCs or in the hemoglobin level within those cells.</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker">‚Ä¢</span><span class="list-content">Iron deficiency anemia (hypochromic microcytic)</span></li>
                                <li class="list-item"><span class="list-marker">‚Ä¢</span><span class="list-content">Vitamin C (citrus fluids) enhances absorption of iron.</span></li>
                                <li class="list-item"><span class="list-marker">‚Ä¢</span><span class="list-content">Megaloblastic anemia (vitamin B12 and folic acid deficiency).</span></li>
                            </ul>
                        </div>

                        <h3>Iron Preparations:</h3>
                        <p>‚û¢A complex of iron and other substances are normally taken orally.</p>
                        <p>‚û¢Sometimes administered parenterally when:</p>
                        <ul>
                            <li>Some disorders limiting the amount of drug absorbed by GIT.</li>
                            <li>Patient is unable to tolerate oral iron.</li>
                        </ul>
                        <p>‚û¢Iron deficiency is common in infants (low iron in diet), and during pregnancy (increased requirements).</p>
                        
                        <div class="content-card">
                            <p><strong>‚û¢Action:</strong> Iron (diet or drug) absorbed from GIT and transport to bone marrow after combining with protein transferrin, to incorporate with hemoglobin.</p>
                            <p><strong>‚û¢Uses:</strong> prophylaxis and treatment of iron deficiency anemia.</p>
                            <p><strong>‚û¢Contraindications:</strong> Hemosiderosis, peptic ulcer, enteritis, ulcerative colitis and liver cirrhosis.</p>
                            <p><strong>‚û¢Drug interactions:</strong></p>
                            <ul>
                                <li>Antacids: decrease absorption of iron.</li>
                                <li>Tetracycline: iron diminishes affect of tetracycline (decrease its absorption).</li>
                            </ul>
                        </div>

                        <div class="callout callout--danger">
                            <div class="callout-header"><span class="callout-icon">üö´</span><span class="callout-title">Side Effects & Toxicity</span></div>
                            <div class="callout-content">
                                <p><strong>‚û¢Side effects:</strong></p>
                                <ul>
                                    <li>Constipation, gastric irritation, and abdominal cramps, change color of stool to black.</li>
                                    <li>Toxic reaction: (parenteral): causes nausea, vomiting, peripheral vascular collapse. Occurs within 60 seconds of toxic dose. Symptoms may disappear then reappear after 6-24 hours.</li>
                                </ul>
                                <p><strong>‚û¢Treatment of iron toxicity:</strong></p>
                                <ul>
                                    <li>Symptomatic treatment.</li>
                                    <li>Induce vomiting, then give egg and milk.</li>
                                    <li>Gastric lavage may be done with IV NaHco3 solution to counteract acidosis.</li>
                                    <li>Give antidote (chelliating agent); IV infusion of deferoxamine (desferal).</li>
                                </ul>
                            </div>
                        </div>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                            <div class="callout-content">
                                <ul>
                                    <li>Take a complete history, including use of antacids.</li>
                                    <li>Ask about any evidence of GI bleeding.</li>
                                    <li>Advise client to take iron with meals to reduce gastric irritation.</li>
                                    <li>Take iron with citrus juices to enhance absorption.</li>
                                    <li>Advise client not to take iron with milk, tea, or antacids (they decrease iron absorption).</li>
                                    <li>Encourage client to eat a well balanced diet.</li>
                                    <li>Keep drug out of reach of children (extremely toxic).</li>
                                    <li>When administering iron to child, dilute it with water or fruit juice & use a straw to minimize teeth staining.</li>
                                    <li>Discuss with client the possibility of indigestion, changes in stool color (black) and constipation.</li>
                                </ul>
                            </div>
                        </aside>

                        <h3>1) Ferrus Sulfate: Ferrograd, Eryfer</h3>
                        <div class="content-card">
                            <p><strong>‚û¢Class:</strong> antianemic, iron</p>
                            <p><strong>‚û¢Advantages:</strong></p>
                            <ul>
                                <li>Less expensive</li>
                                <li>Most effective oral preparation.</li>
                                <li>More stable in air.</li>
                            </ul>
                            <p><strong>‚û¢Dose:</strong> Elixir, oral solution, tablets, enteric-coated tablets.</p>
                            <ul>
                                <li>Prophylaxis: 300 mg daily.</li>
                                <li>Treatment: 300 mg bid.</li>
                            </ul>
                        </div>

                        <h3>2) Iron dextran injection: imferon</h3>
                        <div class="content-card">
                            <p><strong>‚û¢Class.:</strong> Iron preparation, parenteral.</p>
                            <p><strong>‚û¢‚ÄïThe only iron preparation used parenterally‚Äñ</strong></p>
                            <p><strong>‚û¢Uses:</strong> IM or IV for iron deficiency anemia when oral administration is not possible.</p>
                            <p><strong>‚û¢Side effects:</strong> Anaphylaxis, rashes, nausea, vomiting, diarrhea, hypotension, tachycardia, shock.</p>
                            <ul>
                                <li>IM: causes brown skin, abscess formation.</li>
                                <li>IV: leads to phlebitis.</li>
                            </ul>
                            <p><strong>‚û¢Nursing considerations:</strong></p>
                            <ul>
                                <li>Should never be mixed with other medications or added to parenteral nutrition.</li>
                                <li>Obtain vital signs to determine client‚Äôs response to therapy.</li>
                                <li>Give the drug IM deeply or IV slowly.</li>
                                <li>Prevent staining of skin by using a separate needle.</li>
                                <li>Be prepared to assist with treatment of iron intoxication.</li>
                            </ul>
                        </div>

                        <h3>Folic acid (Generic Name: Folvite)</h3>
                        <div class="content-card">
                            <p><strong>Action</strong><br>
                            Stimulates production of red and white blood cells and platelets in some megaloblastic anemias.</p>
                            
                            <p><strong>Indications and dosages</strong></p>
                            <ul>
                                <li>Recommended dietary allowance</li>
                                <li>Megaloblastic anemia related to folic acid deficiency in nutritional deficiency, pregnancy, childhood, or infancy.</li>
                                <li>Folate deficiency</li>
                            </ul>
                            <p><strong>Dose:</strong> 150 to 400 mcg, up to 1 mg/day</p>
                            
                            <p><strong>Contraindications and precautions</strong></p>
                            <ul>
                                <li>Contraindicated in pernicious, aplastic, or normocytic anemia</li>
                                <li>Use cautiously in breastfeeding patients.</li>
                            </ul>
                            
                            <p><strong>Adverse reactions</strong><br>
                            Altered sleep pattern, malaise, poor concentration, impaired judgment, hyperactivity, anorexia, nausea, flatulence, bitter taste, allergic reaction (including rash, pruritus, erythema), Bronchospasm.</p>
                            
                            <p><strong>Nursing Considerations:</strong></p>
                            <ol>
                                <li>Teach woman about importance of taking daily dose 3 months before pregnancy and in first trimester as it decreases fetal neural tube defects by 50%.</li>
                                <li>It is not effective in normocytic anemias</li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: antianemic-drugs -->

                    <!-- START: anticoagulants-hemostatics -->
                    <section id="anticoagulants-hemostatics" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">Anticoagulants & Hemostatics</h2>
                        </div>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="list-marker">‚û¢</span><span class="list-content">Prothrombin (thromboplastion ) thrombin</span></li>
                            <li class="list-item"><span class="list-marker">‚û¢</span><span class="list-content">Fibrinogen (thrombin) fibrin (insoluble protein).</span></li>
                            <li class="list-item"><span class="list-marker">‚û¢</span><span class="list-content">Several factors participate in blood clotting manufactured by the liver as vitamin K. (Liver disease affect blood clotting)</span></li>
                            <li class="list-item"><span class="list-marker">‚û¢</span><span class="list-content">Many diseases lead to defect of coagulation (hemophilia, C.V. diseases).</span></li>
                        </ul>

                        <h3>1) Warfarin sodium: coumadin</h3>
                        <div class="content-card">
                            <p><strong>‚û¢Class:</strong> anticoagulant.</p>
                            <p><strong>‚û¢Action:</strong> prevent the formation of factors II, VII, IX and X in the liver.</p>
                            <p><strong>‚û¢Uses:</strong></p>
                            <ul>
                                <li>Prophylaxis and treatment of deep venous thrombosis.</li>
                                <li>Thromboembolison - Thrombophlebitis.</li>
                                <li>Prophylaxis from myocardial infarction.</li>
                            </ul>
                            <p><strong>‚û¢Contraindications:</strong></p>
                            <ul>
                                <li>Hemorrhagic tendencies</li>
                                <li>Blood disorders.</li>
                                <li>Ulcerative lesion of GIT.</li>
                                <li>Impaired renal and hepatic function.</li>
                                <li>Severe hypertension.</li>
                                <li>Thrombocytopnia.</li>
                            </ul>
                            <p><strong>‚û¢Drug interaction:</strong></p>
                            <ul>
                                <li>Antacids: decrease effect of anticoagulants (by decreasing its absorption)</li>
                                <li>Salicylate: effect of anticoagulants.</li>
                            </ul>
                            <p><strong>‚û¢Side effects:</strong> hemorrhagic accidents.</p>
                            <p><strong>‚û¢Antidote:</strong> vitamin K.</p>
                            
                            <aside class="callout callout--info">
                                <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                                <div class="callout-content">
                                    <ul>
                                        <li>Daily monitoring of prothrombin time is recommended.</li>
                                        <li>Instruct clients to take the drug before meal.</li>
                                        <li>Remind clients to wear identification band that states that they are on anticoagulant therapy.</li>
                                        <li>Advise client to avoid activities that may cause injury.</li>
                                        <li>Vitamin K should be available</li>
                                        <li>Food rich in vitamin K should be avoided.</li>
                                    </ul>
                                </div>
                            </aside>
                        </div>

                        <h3>2) Heparin:</h3>
                        <div class="content-card">
                            <p><strong>‚û¢Class:</strong> anticoagulant</p>
                            <p>‚û¢Naturally occurring substance isolated from porcine intestinal mucosa or bovine lung tissue.</p>
                            <p>‚û¢Must be given parentally.</p>
                            <p>‚û¢Doesn‚Äôt interfere with wound healing.</p>
                            <p><strong>‚û¢Action:</strong> Potentiate the inhibitory action of antithrombin III on various coagulation factors. Inactivate thrombin and prevent the conversion of fibrinogen to fibrin.</p>
                            <p><strong>‚û¢Uses:</strong></p>
                            <ul>
                                <li>To prevent extension of clots.</li>
                                <li>To prevent thrombi and emboli from recurring.</li>
                                <li>Prophylactic from thromboembolic diseases.</li>
                                <li>After some types of surgery (cardiac, orthopedic & vascular).</li>
                                <li>Prevent clotting during hemodialysis.</li>
                                <li>Treatment of DIC (disseminated intravasculor coagulation)</li>
                                <li>Coronary occlusion after MI.</li>
                            </ul>
                            <p><strong>‚û¢Contraindications:</strong></p>
                            <ul>
                                <li>Blood disorders with bleeding tendencies (hemophilia).</li>
                                <li>Suspected intracranial hemorrhage.</li>
                                <li>Open wounds.</li>
                                <li>During surgery of the eyes, brain and spinal cord.</li>
                                <li>Menstruation.</li>
                                <li>Abortion.</li>
                                <li>Any drugs or conditions affecting blood coagulation.</li>
                            </ul>
                            <p><strong>‚û¢Side effects:</strong> Hemorrhage.</p>
                            <p><strong>‚û¢Overdose:</strong> nose bleeding, hematouria, petechiae, tarry stool.</p>
                            <p><strong>‚û¢Antidote:</strong> protamin sulfate.</p>
                            <p><strong>‚û¢Dose:</strong> IV or S.C measured in units according to bleeding & clotting time.</p>
                            
                            <aside class="callout callout--info">
                                <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                                <div class="callout-content">
                                    <ul>
                                        <li>Should not be administered IM, administer by deep sc to minimize local irritation and to prolong the action of drug.</li>
                                        <li>Don‚Äôt massage before and after injection.</li>
                                        <li>Change site of administration to avoid ecchymosis.</li>
                                        <li>Instruct and stress the importance of reporting any signs of active bleeding.</li>
                                        <li>Use electric razor for shaving, soft bristle tooth brush to decrease gum irritation.</li>
                                        <li>Patient should be hospitalized for IV therapy.</li>
                                        <li>Clotting time, PTT should be done before the start of therapy each dose of drug then daily.</li>
                                    </ul>
                                </div>
                            </aside>
                        </div>

                        <h3>3) Enoxaparin sodium</h3>
                        <div class="content-card">
                            <p><strong>Trade name:</strong> Clexane , Lovenox 3</p>
                            <p><strong>Class:</strong> Anticoagulant, low-molecularweight heparin.</p>
                            <p>‚û¢Pregnancy risk category B</p>
                            <p><strong>Action:</strong> Inhibits thrombus and clot formation by blocking factor Xa and factor IIa. This inhibition accelerates formation of antithrombin III-thrombin complex (a coagulation inhibitor), thereby deactivating thrombin and preventing conversion of fibrinogen to fibrin.</p>
                            
                            <p><strong>Indications and dosages</strong></p>
                            <ul>
                                <li>Patients at risk for thromboembolic complications (pulmonary embolism and deep-vein thrombosis) due to severely restricted mobility during acute illness or post a major surgery.</li>
                                <li>Prevent blood clots.</li>
                                <li>In some cases of pregnancy (sometime, a blood clot is formed in the umbilical cord due to antiphispholid syndrome, which leads to miscourage).</li>
                            </ul>
                            <p><strong>‚û¢Adults:</strong> 40 mg subcutaneously daily</p>
                            
                            <p><strong>Contraindications</strong></p>
                            <ul>
                                <li>Hypersensitivity to clexane or heparin.</li>
                                <li>Thrombocytopenia</li>
                                <li>Active major bleeding</li>
                                <li>Major blood disorders</li>
                                <li>Certain types of stroke</li>
                                <li>Do not give Clexane to a child.</li>
                            </ul>
                            
                            <p><strong>Adverse reactions</strong></p>
                            <ul>
                                <li><strong>CNS:</strong> dizziness, headache, insomnia, confusion, cerebrovascular accident</li>
                                <li><strong>CV:</strong> edema, chest pain, atrial fibrillation, heart failure</li>
                                <li><strong>GI:</strong> nausea, vomiting, constipation</li>
                                <li><strong>GU:</strong> urinary retention</li>
                                <li><strong>Hematologic:</strong> anemia, bleeding tendency, thrombocytopenia, hemorrhage</li>
                                <li><strong>Skin:</strong> bruising, pruritus, rash, urticaria, irritation, or erythema at injection site</li>
                            </ul>

                            <aside class="callout callout--info">
                                <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                                <div class="callout-content">
                                    <ul>
                                        <li>I.M. injection may be painful. Monitor sites for evidence of sterile abscess.</li>
                                        <li>Rotate injection sites to prevent muscle atrophy.</li>
                                        <li>Monitor patient for pain and swelling, warmth, or redness in calves; sudden, severe headaches; visual disturbances; numbness in extremities; signs of depression; signs of liver dysfunction (abdominal pain, dark urine, jaundice).</li>
                                        <li>Advise patient to take medication with food if GI upset occurs.</li>
                                        <li><strong>Alert:</strong> Tell patient to report unusual symptoms immediately and to stop drug and notify doctor about visual disturbances or migraine.</li>
                                        <li>Teach woman how to perform routine breast self-examination.</li>
                                        <li>Advice patient to immediately report to doctor any breast abnormalities, vaginal bleeding, swelling, yellowish skin or eyes, dark urine, shortness of breath, chest pain, or pregnancy.</li>
                                        <li>Advise patient that injection must be given every 3 months to maintain adequate contraceptive effects.</li>
                                    </ul>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: anticoagulants-hemostatics -->

                    <!-- START: vitamin-k -->
                    <section id="vitamin-k" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">Phytonadione (vitamin K1)</h2>
                        </div>
                        <div class="content-card">
                            <p><strong>‚û¢Class:</strong> Vitamin</p>
                            <p><strong>‚û¢Action:</strong> Promotes hepatic synthesis of active prothrombin.</p>
                            <p><strong>‚û¢Indications:</strong></p>
                            <ul>
                                <li>Hypoprothrombinemia caused by anticoagulant therapy</li>
                                <li>Hypoprothrombinemia secondary to other causes</li>
                                <li>Prevention and treatment of hemorrhagic disease of newborn</li>
                            </ul>
                            <p><strong>‚û¢Neonates:</strong> For prevention, 0.5 to 1 mg I.M. as a single dose within 1 hour of birth.</p>
                            
                            <p><strong>Contraindications and precautions</strong></p>
                            <ul>
                                <li>Contraindicated in hypersensitivity to drug</li>
                                <li>Use cautiously in pregnant or breastfeeding patients, and children.</li>
                            </ul>
                            
                            <p><strong>Adverse reactions</strong></p>
                            <ul>
                                <li>Hyperbilirubinemia (in infants); with parenteral administration‚Äî pain, swelling, tenderness at injection site; itchy rash after repeated injections; transient flushing sensations; anaphylic reaction.</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: vitamin-k -->

                    <!-- START: thrombolytics-antifibrinolytics -->
                    <section id="thrombolytics-antifibrinolytics" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">Thrombolytic Agents</h2>
                        </div>
                        <p>‚ñ™ Agents used to promote the dissolution(lysis ) of the insoluble fibrin trapped in intravascular emboli and thrombi.</p>
                        <ul>
                            <li>The most serious complication is hemorrhage.</li>
                            <li>Heparin therapy usually follows treatment with these agents.</li>
                        </ul>

                        <div class="content-card">
                            <h4>1- Streptokinase:</h4>
                            <p><strong>Class:</strong> Thrombolytic agent.</p>
                            <p><strong>Action:</strong> Acts with plasminogen to produce an activator complex which enhance the conversion of plasminogen to plasmin which breaks down fibrinogen, fibrin clot & other plasma proteins.</p>
                            <p><strong>Uses:</strong> Deep venous thrombosis (DVT), Myocardial infarction (MI), To clear occluded arteriovenous or IV canula.</p>
                            <p><strong>Contraindication:</strong> Hemorrhage.</p>
                            <p><strong>Side effects:</strong> Bleeding, nausea, and headache.</p>
                        </div>

                        <h3>Antifibrinolytic agents</h3>
                        <div class="content-card">
                            <h4>Tranexamic acid</h4>
                            <p><strong>Trade Name:</strong> Hexacaprone</p>
                            <p><strong>Classification:</strong> Antifibrinolytic</p>
                            <p><strong>Uses:</strong> Prevention of heavy bleeding such as heavy periods, nose bleeds. Prevention of bleeding during tooth extraction in <em>haemophiliacs</em> (people who lack a clotting factor)</p>
                            <p><strong>Contraindications:</strong> pregnancy, breast feeding, history of thromboembolic disease, kidney problems, bleeding disorders, and menstrual bleeding.</p>
                            <p><strong>Side-effects:</strong> Nausea, vomiting, Diarrhea</p>
                            
                            <aside class="callout callout--info">
                                <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                                <div class="callout-content">
                                    <ol>
                                        <li>To overcome GI problems, instruct patient to eat little and often, and eat simple foods such as dry toast.</li>
                                        <li>Teach patient to drink plenty of fluids.</li>
                                        <li>Watch for thrombus or embolus formation</li>
                                        <li>Teach patient to report sudden slurred speech, loss of co-ordination, pain in the chest or groin or leg you should contact a doctor as soon as possible. If any of these occur, stop taking the medication and see your doctor.</li>
                                    </ol>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: thrombolytics-antifibrinolytics -->

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-07-antineoplastics.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Antineoplastic Agents</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-09-cardiovascular.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Cardiovascular Drugs</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>